Jesse Mez

13.9k total citations · 2 hit papers
126 papers, 3.0k citations indexed

About

Jesse Mez is a scholar working on Epidemiology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Jesse Mez has authored 126 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 52 papers in Psychiatry and Mental health and 37 papers in Physiology. Recurrent topics in Jesse Mez's work include Dementia and Cognitive Impairment Research (50 papers), Traumatic Brain Injury Research (40 papers) and Alzheimer's disease research and treatments (34 papers). Jesse Mez is often cited by papers focused on Dementia and Cognitive Impairment Research (50 papers), Traumatic Brain Injury Research (40 papers) and Alzheimer's disease research and treatments (34 papers). Jesse Mez collaborates with scholars based in United States, United Kingdom and Sweden. Jesse Mez's co-authors include Robert A. Stern, Michael L. Alosco, Ann C. McKee, Yorghos Tripodis, Daniel H. Daneshvar, Rhoda Au, Thor D. Stein, Robert C. Cantu, Philip H. Montenigro and Brett Martin and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jesse Mez

113 papers receiving 2.9k citations

Hit Papers

Cumulative Head Impact Exposure Predicts Later-Life Depre... 2016 2026 2019 2022 2016 2023 100 200 300

Peers

Jesse Mez
Raquel C. Gardner United States
Brent E. Masel United States
Nathan R. Selden United States
Kyle Womack United States
P. David Adelson United States
Raquel C. Gardner United States
Jesse Mez
Citations per year, relative to Jesse Mez Jesse Mez (= 1×) peers Raquel C. Gardner

Countries citing papers authored by Jesse Mez

Since Specialization
Citations

This map shows the geographic impact of Jesse Mez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Mez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Mez more than expected).

Fields of papers citing papers by Jesse Mez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse Mez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Mez. The network helps show where Jesse Mez may publish in the future.

Co-authorship network of co-authors of Jesse Mez

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse Mez. A scholar is included among the top collaborators of Jesse Mez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse Mez. Jesse Mez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallée, Jeanne, Laura E. Gibbons, Seo‐Eun Choi, et al.. (2025). Facets of language performance in early‐onset and late‐onset Alzheimer's disease dementia. Alzheimer s & Dementia. 21(9). e70705–e70705.
2.
Wang, Yixuan, Thor D. Stein, Ting Fang Alvin Ang, et al.. (2025). The impact of blood MCP-1 levels on Alzheimer’s disease with genetic variation at the NAV3 and UNC5C loci. Translational Psychiatry. 15(1). 296–296.
3.
Ding, Huitong, Moira McNulty, Phillip H Hwang, et al.. (2025). Exploring nightly variability and clinical influences on sleep measures: insights from a digital brain health platform. Sleep Medicine. 131. 106532–106532.
4.
Yuan, Jing, Qiushan Tao, Ting Fang Alvin Ang, et al.. (2024). The Relationship between Framingham Stroke Risk Profile on Incident Dementia and Alzheimer's Disease: A 40‐Year Follow‐Up Study Highlighting Female Vulnerability. Annals of Neurology. 96(6). 1124–1134. 3 indexed citations
5.
Chen, Jiachen, Ahmed A.Y. Ragab, Margaret F. Doyle, et al.. (2024). Inflammatory protein associations with brain MRI measures: Framingham Offspring Cohort. Alzheimer s & Dementia. 20(11). 7465–7478. 4 indexed citations
6.
Blennow, Kaj, Henrik Zetterberg, Yorghos Tripodis, et al.. (2024). Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer Disease. Neurology. 103(11). e209866–e209866. 3 indexed citations
7.
Tripodis, Yorghos, Michael L. Alosco, Jesse Mez, et al.. (2023). Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative. Neurobiology of Aging. 127. 33–42. 3 indexed citations
8.
Crane, Paul K., Colin Groot, Rik Ossenkoppele, et al.. (2023). Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns. Alzheimer s & Dementia. 20(3). 1739–1752. 8 indexed citations
9.
Labadorf, Adam, Nurgül Aytan, Jonathan D. Cherry, et al.. (2023). Inflammation and neuronal gene expression changes differ in early versus late chronic traumatic encephalopathy brain. BMC Medical Genomics. 16(1). 49–49. 5 indexed citations
10.
Doyle, Margaret F., Jiachen Chen, Jesse Mez, et al.. (2023). Circulating immune cell phenotypes are associated with age, sex, CMV, and smoking status in the Framingham Heart Study offspring participants. Aging. 15(10). 3939–3966. 8 indexed citations
11.
Sugarman, Michael A., Henrik Zetterberg, Kaj Blennow, et al.. (2023). Sex Differences on Tau, Astrocytic and Neurodegeneration Plasma Biomarkers. Alzheimer s & Dementia. 19(S14). 3 indexed citations
12.
Cherry, Jonathan D., Raymond Nicks, Madeline Uretsky, et al.. (2023). Three dimensional evaluation of cerebrovascular density and branching in chronic traumatic encephalopathy. Acta Neuropathologica Communications. 11(1). 123–123. 5 indexed citations
13.
Alosco, Michael L., Charles H. Adler, David W. Dodick, et al.. (2023). Examination of parkinsonism in former elite American football players. Parkinsonism & Related Disorders. 120. 105903–105903. 3 indexed citations
14.
Yuan, Jing, Rhoda Au, Cody Karjadi, et al.. (2022). Associations Between the Digital Clock Drawing Test and Brain Volume: Large Community-Based Prospective Cohort (Framingham Heart Study). Journal of Medical Internet Research. 24(4). e34513–e34513. 10 indexed citations
15.
Tao, Qiushan, Ting Fang Alvin Ang, John J. Farrell, et al.. (2022). The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer’s disease. Translational Psychiatry. 12(1). 523–523. 11 indexed citations
16.
Cherry, Jonathan D., Soong Ho Kim, Thor D. Stein, et al.. (2020). Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy. Brain Pathology. 30(5). 913–925. 39 indexed citations
17.
Cherry, Jonathan D., Gaoyuan Meng, Sarah Daley, et al.. (2020). CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy. Journal of Neuroinflammation. 17(1). 370–370. 50 indexed citations
18.
Mian, Asim, Anna M. Cervantes‐Arslanian, Eric Steinberg, et al.. (2019). Differentiating Between Healthy Control Participants and Those with Mild Cognitive Impairment Using Volumetric MRI Data. Journal of the International Neuropsychological Society. 25(8). 800–810. 16 indexed citations
19.
Mez, Jesse, Jessica R. Marden, Shubhabrata Mukherjee, et al.. (2017). Alzheimer's disease genetic risk variants beyond APOE ε4 predict mortality.. eScholarship (California Digital Library). 1 indexed citations
20.
Cherry, Jonathan D., Thor D. Stein, Yorghos Tripodis, et al.. (2017). CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease. PLoS ONE. 12(9). e0185541–e0185541. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026